From Drug Benefit News - Putting a new spin on the narrow pharmacy network trend, CVS Health’s PBM may soon penalize customers who choose to obtain prescriptions from other tobacco-selling locations through the creation of what could be the first tobacco-free pharmacy network. While CVS/caremark says the network is being developed in response to client demand, several benefit consultants that work with large plan sponsors tell DBN they haven’t observed a need for this kind of network among their own client base. Read more
From Specialty Pharmacy News - Pharmaceutical manufacturers are maintaining their research-and-development focus on oncology, with 771 therapies, including vaccines, in the pipeline, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA), released Oct. 7. And while many innovative products are coming onto the U.S. market, there are many more that fail during clinical trials. Read more
From Specialty Pharmacy News - After Gilead Sciences, Inc.’s hepatitis C therapy Sovaldi (sofosbuvir) launched in December, much of the attention on the drug has focused on its $1,000-per-day price. But in clinical trials, the drug had sustained virologic response rates of more than 90%, making it much more effective than any previous therapy. Read more
Check out all of the benefits, sample issues & more!